New-Competitive- Principal of Tumor Control by Low Dose Radiation

A. N. Shoutko, L. Yurkova, K. S. Borodulya, L. P. Ekimova
{"title":"New-Competitive- Principal of Tumor Control by Low Dose Radiation","authors":"A. N. Shoutko, L. Yurkova, K. S. Borodulya, L. P. Ekimova","doi":"10.9734/bpi/nfmmr/v12/12422d","DOIUrl":null,"url":null,"abstract":"In order to verify the principle of indirect control a tumor on the base of morphogenic cells distraction from it, the 114 patients with advanced ovarian carcinoma (stage III-56, stage IY-21, relapse 37), were treated with subtotal half-body (low part) irradiation at low doses (0,1 Gy x 10 for 3 weeks or 3Gy x 3 daily), and obtained data were compared with that for 190 patients (stage III-66, stage IY-25, relapse-99) received conventional local irradiation of the tumor (2 Gy x 23 daily). The surgery and chemotherapy components were equalized in both groups. The 34% and 11% of 5-years survival was obtained at low dose half body irradiation for primary and relapsed patients in comparison with conventional local radiotherapy (7% and 0%). It is concluded, that reparation /regeneration processes being provoked artificially in normal tissues of cancer host are capable to compete remotely with tumor for the morphogenic/feeding cells originated from bone marrow and circulating with the blood.","PeriodicalId":118581,"journal":{"name":"New Frontiers in Medicine and Medical Research Vol. 12","volume":"216 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Frontiers in Medicine and Medical Research Vol. 12","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/nfmmr/v12/12422d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In order to verify the principle of indirect control a tumor on the base of morphogenic cells distraction from it, the 114 patients with advanced ovarian carcinoma (stage III-56, stage IY-21, relapse 37), were treated with subtotal half-body (low part) irradiation at low doses (0,1 Gy x 10 for 3 weeks or 3Gy x 3 daily), and obtained data were compared with that for 190 patients (stage III-66, stage IY-25, relapse-99) received conventional local irradiation of the tumor (2 Gy x 23 daily). The surgery and chemotherapy components were equalized in both groups. The 34% and 11% of 5-years survival was obtained at low dose half body irradiation for primary and relapsed patients in comparison with conventional local radiotherapy (7% and 0%). It is concluded, that reparation /regeneration processes being provoked artificially in normal tissues of cancer host are capable to compete remotely with tumor for the morphogenic/feeding cells originated from bone marrow and circulating with the blood.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低剂量辐射控制肿瘤的新竞争原理
为了验证间接控制肿瘤的原则的基础上地貌成因的细胞分散,114年晚期卵巢癌患者癌(IY-21 III-56阶段,阶段,复发37),服用小计一半身体(低部分)在低剂量辐照(0,1 Gy x 10 3周或3 Gy x 3日报),和获得的数据相比,190名患者(阶段3 - 66、舞台IY-25、复发- 99)接受传统的局部照射肿瘤(2 Gy x 23日报)。两组的手术和化疗成分相等。与常规局部放疗(7%和0%)相比,低剂量半体照射对原发和复发患者的5年生存率分别为34%和11%。由此可见,在肿瘤宿主的正常组织中,人工激活的修复/再生过程能够与肿瘤进行远程竞争,争夺来自骨髓并随血液循环的形态形成/喂养细胞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Case Report on Persistent Mullerian Duct Syndrome Epidemiology of Foot and Mouth Disease (FMD) in South Sudan: A Review Study on Herbal Medicines, Ascorbic Acid, Cyanocobalamin, Tenofovir, Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B: A Combination of Treatment with Herbs Diagnostic Dilemma Associated with Rhinomaxillary Mucormycosis: A Case Report of a Non COVID-19 Patient Study on Evaluation of Laparoscopic Retroperitoneal Approach for Management of Various Renal Calculi
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1